1. Home
  2. JBLU vs NUVB Comparison

JBLU vs NUVB Comparison

Compare JBLU & NUVB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo JetBlue Airways Corporation

JBLU

JetBlue Airways Corporation

HOLD

Current Price

$5.00

Market Cap

1.8B

ML Signal

HOLD

NUVB

Nuvation Bio Inc.

HOLD

Current Price

$4.92

Market Cap

1.7B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
JBLU
NUVB
Founded
1998
2018
Country
United States
United States
Employees
N/A
307
Industry
Air Freight/Delivery Services
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.8B
1.7B
IPO Year
2002
N/A

Fundamental Metrics

Financial Performance
Metric
JBLU
NUVB
Price
$5.00
$4.92
Analyst Decision
Sell
Strong Buy
Analyst Count
13
8
Target Price
$4.91
$11.38
AVG Volume (30 Days)
23.9M
4.3M
Earning Date
04-28-2026
05-04-2026
Dividend Yield
N/A
N/A
EPS Growth
27.83
N/A
EPS
N/A
N/A
Revenue
$9,062,000,000.00
N/A
Revenue This Year
$12.11
$203.82
Revenue Next Year
$6.75
$58.18
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$3.87
$1.57
52 Week High
$6.46
$9.75

Technical Indicators

Market Signals
Indicator
JBLU
NUVB
Relative Strength Index (RSI) 51.75 53.69
Support Level $4.90 $4.07
Resistance Level $5.15 $5.16
Average True Range (ATR) 0.24 0.37
MACD -0.01 0.00
Stochastic Oscillator 43.90 39.52

Price Performance

Historical Comparison
JBLU
NUVB

About JBLU JetBlue Airways Corporation

JetBlue Airways Corp is a low-cost airline that offers high-quality service, including assigned seating and in-flight entertainment. It served approximately 100 destinations in the United States, the Caribbean and Latin America, Canada, and England. The company currently operates Airbus A321, Airbus A320, Airbus A321neo, and Embraer E190 aircraft types. The company has one operating segment, Air Transportation Services, which provides services in the United States, the Caribbean, Latin America, Canada, and Europe. The majority of revenue is generated from the Domestic & Canada segment.

About NUVB Nuvation Bio Inc.

Nuvation Bio Inc is a biopharmaceutical company tackling unmet needs in oncology by developing differentiated and novel therapeutic candidates. Its product candidate, taletrectinib, is an oral, potent, central nervous system-active, selective, next-generation c-ros oncogene 1 (ROS1) inhibitor designed for the treatment of patients with ROS1+ non-small cell lung cancer (NSCLC). In addition, its clinical-stage pipeline includes oncology product candidates such as Safusidenib, NUV-1511, and NUV-868 in different stages of development. The Company generates revenue from out-licensing collaborative agreements, including product revenue, upfront license fees, royalty revenue, and research and development services revenue. The Company generates the majority of its revenue from Japan.

Share on Social Networks: